Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Synthetic cathinone adulteration of illegal drugs.

Oliver CF, Palamar JJ, Salomone A, Simmons SJ, Philogene-Khalid HL, Stokes-McCloskey N, Rawls SM.

Psychopharmacology (Berl). 2018 Oct 18. doi: 10.1007/s00213-018-5066-6. [Epub ahead of print] Review.

PMID:
30338489
2.

Coadministration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats.

Inan S, Eisenstein TK, Watson MN, Doura M, Meissler JJ, Tallarida CS, Chen X, Geller EB, Rawls SM, Cowan A, Adler MW.

J Pharmacol Exp Ther. 2018 Dec;367(3):433-441. doi: 10.1124/jpet.118.252890. Epub 2018 Sep 24.

PMID:
30249618
3.

Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians.

Dziedowiec E, Nayak SU, Gruver KS, Jennings T, Tallarida CS, Rawls SM.

Neuroscience. 2018 Aug 21;386:214-222. doi: 10.1016/j.neuroscience.2018.06.029. Epub 2018 Jun 27.

PMID:
29958944
4.

DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants.

Simmons SJ, Leyrer-Jackson JM, Oliver CF, Hicks C, Muschamp JW, Rawls SM, Olive MF.

ACS Chem Neurosci. 2018 Oct 17;9(10):2379-2394. doi: 10.1021/acschemneuro.8b00147. Epub 2018 May 11.

PMID:
29714473
5.

Dopamine D1-Like Receptor Agonist and D2-Like Receptor Antagonist (-)-Stepholidine Reduces Reinstatement of Drug-Seeking Behavior for 3,4-Methylenedioxypyrovalerone (MDPV) in Rats.

Hicks C, Huang P, Ramos L, Nayak SU, Caro Y, Reitz AB, Smith GR, Lee DY, Rawls SM, Liu-Chen LY.

ACS Chem Neurosci. 2018 Jun 20;9(6):1327-1337. doi: 10.1021/acschemneuro.7b00510. Epub 2018 Apr 6.

PMID:
29597343
6.

Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats.

Oliver CF, Simmons SJ, Nayak SU, Smith GR, Reitz AB, Rawls SM.

Drug Alcohol Depend. 2018 May 1;186:75-79. doi: 10.1016/j.drugalcdep.2018.01.013. Epub 2018 Mar 10.

PMID:
29550625
7.

PLDT (planarian light/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects.

Zewde AM, Yu F, Nayak S, Tallarida C, Reitz AB, Kirby LG, Rawls SM.

J Neurosci Methods. 2018 Jan 1;293:284-288. doi: 10.1016/j.jneumeth.2017.10.010. Epub 2017 Oct 16.

PMID:
29042260
8.

Stereoselective Differences between the Reinforcing and Motivational Effects of Cathinone-Derived 4-Methylmethcathinone (Mephedrone) In Self-Administering Rats.

Philogene-Khalid HL, Simmons SJ, Nayak S, Martorana RM, Su SH, Caro Y, Ranieri B, DiFurio K, Mo L, Gentile TA, Murad A, Reitz AB, Muschamp JW, Rawls SM.

ACS Chem Neurosci. 2017 Dec 20;8(12):2648-2654. doi: 10.1021/acschemneuro.7b00212. Epub 2017 Sep 22.

PMID:
28885007
9.

Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats.

Simmons SJ, Martorana R, Philogene-Khalid H, Tran FH, Gentile TA, Xu X, Su S, Rawls SM, Muschamp JW.

Psychopharmacology (Berl). 2017 Nov;234(21):3207-3215. doi: 10.1007/s00213-017-4709-3. Epub 2017 Aug 7.

10.

Effects of ceftriaxone on conditioned nicotine reward in rats.

Philogene-Khalid HL, Simmons SJ, Muschamp JW, Rawls SM.

Behav Pharmacol. 2017 Sep;28(6):485-488. doi: 10.1097/FBP.0000000000000314.

11.

Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats.

Philogene-Khalid HL, Hicks C, Reitz AB, Liu-Chen LY, Rawls SM.

Drug Alcohol Depend. 2017 Sep 1;178:119-125. doi: 10.1016/j.drugalcdep.2017.04.024. Epub 2017 Jun 13.

12.

Factors affecting increased risk for substance use disorders following traumatic brain injury: What we can learn from animal models.

Merkel SF, Cannella LA, Razmpour R, Lutton E, Raghupathi R, Rawls SM, Ramirez SH.

Neurosci Biobehav Rev. 2017 Jun;77:209-218. doi: 10.1016/j.neubiorev.2017.03.015. Epub 2017 Mar 28. Review.

13.

Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).

Hicks C, Gregg RA, Nayak SU, Cannella LA, Schena GJ, Tallarida CS, Reitz AB, Smith GR, Rawls SM.

Psychopharmacology (Berl). 2017 Jun;234(11):1671-1681. doi: 10.1007/s00213-017-4568-y. Epub 2017 Mar 1.

14.

KCNQ2/3 channel agonist flupirtine reduces cocaine place preference in rats.

Mooney J, Rawls SM.

Behav Pharmacol. 2017 Aug;28(5):405-407. doi: 10.1097/FBP.0000000000000287.

15.

Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.

Simmons SJ, Gregg RA, Tran FH, Mo L, von Weltin E, Barker DJ, Gentile TA, Watterson LR, Rawls SM, Muschamp JW.

Addict Biol. 2018 Jan;23(1):102-110. doi: 10.1111/adb.12479. Epub 2016 Dec 1.

PMID:
27910188
16.

Behavioral effects of Splenda, Equal and sucrose: Clues from planarians on sweeteners.

Ouyang K, Nayak S, Lee Y, Kim E, Wu M, Tallarida CS, Rawls SM.

Neurosci Lett. 2017 Jan 1;636:213-217. doi: 10.1016/j.neulet.2016.11.017. Epub 2016 Nov 11.

17.

Chemokines and cocaine: CXCR4 receptor antagonist AMD3100 attenuates cocaine place preference and locomotor stimulation in rats.

Kim J, Connelly KL, Unterwald EM, Rawls SM.

Brain Behav Immun. 2017 May;62:30-34. doi: 10.1016/j.bbi.2016.08.015. Epub 2016 Aug 26.

18.

Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator.

Gregg RA, Hicks C, Nayak SU, Tallarida CS, Nucero P, Smith GR, Reitz AB, Rawls SM.

Neuropharmacology. 2016 Sep;108:111-9. doi: 10.1016/j.neuropharm.2016.04.014. Epub 2016 Apr 13.

19.

Benzodiazepine inhibits anxiogenic-like response in cocaine or ethanol withdrawn planarians.

Nayak S, Roberts A, Bires K, Tallarida CS, Kim E, Wu M, Rawls SM.

Behav Pharmacol. 2016 Sep;27(6):556-8. doi: 10.1097/FBP.0000000000000236.

20.

Adolescent Traumatic Brain Injury Induces Chronic Mesolimbic Neuroinflammation with Concurrent Enhancement in the Rewarding Effects of Cocaine in Mice during Adulthood.

Merkel SF, Razmpour R, Lutton EM, Tallarida CS, Heldt NA, Cannella LA, Persidsky Y, Rawls SM, Ramirez SH.

J Neurotrauma. 2017 Jan 1;34(1):165-181. doi: 10.1089/neu.2015.4275. Epub 2016 Jun 7.

21.

Clavulanic acid enhances glutamate transporter subtype I (GLT-1) expression and decreases reinforcing efficacy of cocaine in mice.

Kim J, John J, Langford D, Walker E, Ward S, Rawls SM.

Amino Acids. 2016 Mar;48(3):689-696. doi: 10.1007/s00726-015-2117-8. Epub 2015 Nov 5.

22.

Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat.

Barr JL, Rasmussen BA, Tallarida CS, Scholl JL, Forster GL, Unterwald EM, Rawls SM.

Br J Pharmacol. 2015 Nov;172(22):5414-24. doi: 10.1111/bph.13330. Epub 2015 Oct 22.

23.

Levamisole enhances the rewarding and locomotor-activating effects of cocaine in rats.

Tallarida CS, Tallarida RJ, Rawls SM.

Drug Alcohol Depend. 2015 Apr 1;149:145-50. doi: 10.1016/j.drugalcdep.2015.01.035. Epub 2015 Feb 7.

24.

Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates.

Vouga A, Gregg RA, Haidery M, Ramnath A, Al-Hassani HK, Tallarida CS, Grizzanti D, Raffa RB, Smith GR, Reitz AB, Rawls SM.

Neuropharmacology. 2015 Apr;91:109-16. doi: 10.1016/j.neuropharm.2014.11.010. Epub 2014 Dec 9.

25.

Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats.

Gregg RA, Baumann MH, Partilla JS, Bonano JS, Vouga A, Tallarida CS, Velvadapu V, Smith GR, Peet MM, Reitz AB, Negus SS, Rawls SM.

Br J Pharmacol. 2015 Feb;172(3):883-94. doi: 10.1111/bph.12951. Epub 2014 Dec 15.

26.

Ethanol and cocaine: environmental place conditioning, stereotypy, and synergism in planarians.

Tallarida CS, Bires K, Avershal J, Tallarida RJ, Seo S, Rawls SM.

Alcohol. 2014 Sep;48(6):579-86. doi: 10.1016/j.alcohol.2014.07.006. Epub 2014 Aug 7.

27.

Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug?

Schroeder JA, Tolman NG, McKenna FF, Watkins KL, Passeri SM, Hsu AH, Shinn BR, Rawls SM.

Drug Alcohol Depend. 2014 Sep 1;142:41-5. doi: 10.1016/j.drugalcdep.2014.05.012. Epub 2014 Jun 2.

28.

Cocaine-induced neuroadaptations in the dorsal striatum: glutamate dynamics and behavioral sensitization.

Parikh V, Naughton SX, Shi X, Kelley LK, Yegla B, Tallarida CS, Rawls SM, Unterwald EM.

Neurochem Int. 2014 Sep;75:54-65. doi: 10.1016/j.neuint.2014.05.016. Epub 2014 Jun 6.

PMID:
24911954
29.

Levamisole and cocaine synergism: a prevalent adulterant enhances cocaine's action in vivo.

Tallarida CS, Egan E, Alejo GD, Raffa R, Tallarida RJ, Rawls SM.

Neuropharmacology. 2014 Apr;79:590-5. doi: 10.1016/j.neuropharm.2014.01.002. Epub 2014 Jan 15.

30.

Behavioral pharmacology of designer cathinones: a review of the preclinical literature.

Gregg RA, Rawls SM.

Life Sci. 2014 Feb 27;97(1):27-30. doi: 10.1016/j.lfs.2013.10.033. Epub 2013 Nov 11. Review.

31.

Mephedrone interactions with cocaine: prior exposure to the 'bath salt' constituent enhances cocaine-induced locomotor activation in rats.

Gregg RA, Tallarida CS, Reitz AB, Rawls SM.

Behav Pharmacol. 2013 Dec;24(8):684-8. doi: 10.1097/FBP.0000000000000006.

32.

Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice.

Tallarida CS, Corley G, Kovalevich J, Yen W, Langford D, Rawls SM.

Neurosci Lett. 2013 Nov 27;556:155-9. doi: 10.1016/j.neulet.2013.09.072. Epub 2013 Oct 11.

33.

Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) model.

Raffa RB, Baron S, Bhandal JS, Brown T, Song K, Tallarida CS, Rawls SM.

Pharmacol Biochem Behav. 2013 Nov;112:9-14. doi: 10.1016/j.pbb.2013.09.012. Epub 2013 Sep 29.

PMID:
24084318
34.

Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats.

Gregg RA, Tallarida CS, Reitz A, McCurdy C, Rawls SM.

Drug Alcohol Depend. 2013 Dec 1;133(2):746-50. doi: 10.1016/j.drugalcdep.2013.06.014. Epub 2013 Jul 23.

35.

Sucrose produces withdrawal and dopamine-sensitive reinforcing effects in planarians.

Zhang C, Tallarida CS, Raffa RB, Rawls SM.

Physiol Behav. 2013 Mar 15;112-113:8-13. doi: 10.1016/j.physbeh.2013.02.002. Epub 2013 Feb 13.

36.

Cocaine-induced loss of white matter proteins in the adult mouse nucleus accumbens is attenuated by administration of a β-lactam antibiotic during cocaine withdrawal.

Kovalevich J, Corley G, Yen W, Rawls SM, Langford D.

Am J Pathol. 2012 Dec;181(6):1921-7. doi: 10.1016/j.ajpath.2012.08.013. Epub 2012 Sep 29.

37.

In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism.

Owaisat S, Raffa RB, Rawls SM.

Neurosci Lett. 2012 Sep 6;525(1):12-6. doi: 10.1016/j.neulet.2012.07.052. Epub 2012 Aug 3.

38.

Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation.

Lisek R, Xu W, Yuvasheva E, Chiu YT, Reitz AB, Liu-Chen LY, Rawls SM.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):257-62. doi: 10.1016/j.drugalcdep.2012.04.021. Epub 2012 May 29.

39.

Mephedrone ("bath salt") pharmacology: insights from invertebrates.

Ramoz L, Lodi S, Bhatt P, Reitz AB, Tallarida C, Tallarida RJ, Raffa RB, Rawls SM.

Neuroscience. 2012 Apr 19;208:79-84. doi: 10.1016/j.neuroscience.2012.01.019. Epub 2012 Jan 20.

40.

Cocaine decreases expression of neurogranin via alterations in thyroid receptor/retinoid X receptor signaling.

Kovalevich J, Corley G, Yen W, Kim J, Rawls SM, Langford D.

J Neurochem. 2012 Apr;121(2):302-13. doi: 10.1111/j.1471-4159.2012.07678.x. Epub 2012 Mar 13.

41.

Glutamate transporter activation enhances nicotine antinociception and attenuates nicotine analgesic tolerance.

Schroeder JA, Quick KF, Landry PM, Rawls SM.

Neuroreport. 2011 Dec 21;22(18):970-3. doi: 10.1097/WNR.0b013e32834d87eb.

42.

Glutamate carboxypeptidase II (GCPII) inhibitor displays anti-glutamate and anti-cocaine effects in an invertebrate assay.

Tallarida C, Song K, Raffa RB, Rawls SM.

Amino Acids. 2012 Jun;42(6):2521-4. doi: 10.1007/s00726-011-1052-6. Epub 2011 Aug 18.

43.

Effects of opioids, cannabinoids, and vanilloids on body temperature.

Rawls SM, Benamar K.

Front Biosci (Schol Ed). 2011 Jun 1;3:822-45. Review.

44.

Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 mice.

Ward SJ, Rasmussen BA, Corley G, Henry C, Kim JK, Walker EA, Rawls SM.

Behav Pharmacol. 2011 Aug;22(4):370-3. doi: 10.1097/FBP.0b013e3283473c10.

45.

Nicotine behavioral pharmacology: clues from planarians.

Rawls SM, Patil T, Tallarida CS, Baron S, Kim M, Song K, Ward S, Raffa RB.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):274-9. doi: 10.1016/j.drugalcdep.2011.04.001. Epub 2011 May 6.

46.

Glutamate transporter subtype 1 (GLT-1) activator ceftriaxone attenuates amphetamine-induced hyperactivity and behavioral sensitization in rats.

Rasmussen B, Unterwald EM, Rawls SM.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):484-8. doi: 10.1016/j.drugalcdep.2011.03.022. Epub 2011 Apr 27.

47.

Icilin-evoked behavioral stimulation is attenuated by alpha₂-adrenoceptor activation.

Kim J, Cowan A, Lisek R, Raymondi N, Rosenthal A, Hirsch DD, Rawls SM.

Brain Res. 2011 Apr 12;1384:110-7. doi: 10.1016/j.brainres.2011.02.002.

48.

Topiramate-antagonism of L-glutamate-induced paroxysms in planarians.

Raffa RB, Finno KE, Tallarida CS, Rawls SM.

Eur J Pharmacol. 2010 Dec 15;649(1-3):150-3. doi: 10.1016/j.ejphar.2010.09.021. Epub 2010 Sep 19.

49.

5-HT(1A)-like receptor activation inhibits abstinence-induced methamphetamine withdrawal in planarians.

Rawls SM, Shah H, Ayoub G, Raffa RB.

Neurosci Lett. 2010 Oct 29;484(2):113-7. doi: 10.1016/j.neulet.2010.08.027. Epub 2010 Aug 13.

50.

Glutamate and aspartate measurements in individual planaria by rapid capillary electrophoresis.

Vyas CA, Rawls SM, Raffa RB, Shackman JG.

J Pharmacol Toxicol Methods. 2011 Jan-Feb;63(1):119-22. doi: 10.1016/j.vascn.2010.08.002. Epub 2010 Aug 12.

PMID:
20708699

Supplemental Content

Loading ...
Support Center